Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and reporting resistance to antiviral drugs: study protocol.
Journal article
Arif A. et al, (2023), BMC public health, 23
Phylogenetic Analysis of Hepatitis C Virus Infections in a Large Belgian Cohort Using Next-Generation Sequencing of Full-Length Genomes.
Journal article
Christensen KT. et al, (2023), Viruses, 15
HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV.
Journal article
Cargill T. et al, (2023), JHEP reports : innovation in hepatology, 5
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and in liver transplant recipients.
Journal article
Murray SM. et al, (2023), Journal of hepatology
CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study.
Journal article
Neale I. et al, (2023), mBio
Correction to: Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies.
Journal article
Gillespie IA. et al, (2023), Infectious diseases and therapy
Joint statement in support of hepatitis C human challenge studies.
Journal article
Alter HJ. et al, (2023), The lancet. Gastroenterology & hepatology
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.
Journal article
Hamill V. et al, (2023), BMJ (Clinical research ed.), 382
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history.
Journal article
Hornsby H. et al, (2023), Nature communications, 14
Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies.
Journal article
Gillespie IA. et al, (2023), Infectious diseases and therapy
Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination.
Journal article
Johnson SA. et al, (2023), Clinical and experimental immunology, 212, 249 - 261
An enrichment protocol and analysis pipeline for long read sequencing of the hepatitis B virus transcriptome
Journal article
Ng E. et al, (2023), Journal of General Virology, 104
Defining the key intrahepatic gene networks in HCV infection driven by sex
Journal article
Marchi E. et al, (2023), Gut, 72, 984 - 994
Disparities in care and outcomes for primary liver cancer in England during 2008-2018: a cohort study of 8.52 million primary care population using the QResearch database.
Journal article
Liao W. et al, (2023), EClinicalMedicine, 59
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
Journal article
Murray SM. et al, (2023), Nature Reviews Immunology, 23, 304 - 316
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK.
Journal article
Hamill V. et al, (2023), Liver international : official journal of the International Association for the Study of the Liver, 43, 917 - 927
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses
Journal article
Dijokaite-Guraliuc A. et al, (2023), Cell Reports, 42, 112271 - 112271
Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults
Journal article
Green C. et al, (2023), Clinical and Experimental Immunology, 211, 269 - 279
Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing?
Journal article
Campbell C. et al, (2023), Wellcome Open Research, 7, 203 - 203
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
Journal article
Brevini T. et al, (2023), Nature, 615, 134 - 142